Close Menu
    Facebook X (Twitter) Instagram
    Pro Magzine
    • Home
    • News
      • Top Stories
      • USA
    • Entertainment
      • Movies
      • Celebrity
      • Web series
      • Net worth
    • Business
    • Health
      • Fitness
      • Food & Drink
    • Lifestyle
      • Tattoos
      • Fashion
      • Love & Relationship
      • Messages
      • Sports
      • Travel
    • Tech
      • Internet
      • Gaming
      • SEO
      • Software
      • Tips
    • More
      • Trending
      • Crypto
      • Dogecoin
      • Pets
      • Real Estate
    Pro Magzine
    Home»Health»Study: ketamine infusions alleviate sadness, anxiety, and suicide ideation.

    Study: ketamine infusions alleviate sadness, anxiety, and suicide ideation.

    EmilyeBy EmilyeSeptember 12, 2022Updated:September 12, 2022No Comments3 Mins Read
    Study: ketamine infusions alleviate sadness, anxiety, and suicide ideation.

    Study: ketamine infusions alleviate sadness, anxiety, and suicide ideation. Patients with depression, anxiety, and suicide ideation who received intravenous ketamine at one of three private ketamine infusion clinics showed “substantial improvement,” according to a recent study.

    The new study adds to the expanding body of evidence supporting ketamine’s efficacy in treating these problems; it was published on Monday in the Journal of Clinical Psychiatry.

    According to Dr. Gerard Sanacora, a professor of psychiatry at Yale University School of Medicine, “it delivers some additional real-world evidence, which is tremendously important” since it helps prove its ability to function in a broader general population.

    However, he cautioned that it was impossible to draw any firm conclusions about how the study’s findings should be applied because of important information missing from it, such as statistics on side effects and direct comparisons to alternative options.

    Anesthesia is the primary clinical application for the potent drug ketamine. The powerful high and dissociation effects it produces also make it a popular illegal club drug. Since it is not FDA-approved for the treatment of depression and is therefore used “off-label,” insurance companies will not pay for it even if a doctor prescribes it.

    Between November 2017 and May 2021, researchers examined data from 424 patients with treatment-resistant depression who had infusions of ketamine at one of three Virginia clinics specializing in the treatment of suicidal ideation, depression, or anxiety. Patients filled out mental and physical health questionnaires at each clinic appointment. Six infusions were administered to the patients over the course of 21 days.

    Researchers found that 50% of subjects reacted to infusions within six weeks, with 20% reporting complete remission of depressive symptoms. The response and remission rates were 72% and 38% after 10 treatments, respectively.

    The study found that 50% of patients who had suicidal thoughts experienced remission after 6 weeks and that 30% of patients experienced a reduction in anxiety symptoms throughout treatment.

    Initial response rates were comparable to those of oral medicine and transcranial magnetic stimulation for treatment-resistant depression, according to the study authors. Remission rates were similar to transcranial stimulation but lower than those seen in ECT clinical trials that had been optimized for efficacy and safety.

    The lack of a blinded trial with a control group is one of the research’s drawbacks. It relied on self-reported questionnaires and didn’t consider patients who chose not to receive infusions.

    The study authors admit that they didn’t thoroughly evaluate any potential negative consequences of the medication, but they also highlight that previous research has found no permanent negative effects on memory or cognitive decline.

    Sanacora called it “disappointing” that there was so little known about potential side effects. The “unique collection of risks, both to the individual and to society” associated with ketamine usage include the potential for drug misuse and the unknown repercussions of regular, especially heavy, use.

    However, it is difficult to assess the advantages against the risks without the adverse effects data and without comparing outcomes to a control group or otherwise.

    He argued that while this medication holds great promise for alleviating the suffering caused by severe mood disorders and psychiatric conditions, it must be used with caution and responsibility.

    A nasal spray containing esketamine, a close relative of ketamine, was approved by the US Food and Drug Administration in 2019 for the treatment of depression that had not responded to other therapies. Racemic ketamine (which uses two types of ketamine molecules, in contrast to esketamine’s single form) infusions are less expensive than esketamine, according to the current study’s authors, and may save money if they were reimbursed by insurance.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Emilye

    Related Posts

    Knowing When to Use HCPCS vs CPT Codes: A Guide for Accurate Medical Billing

    June 26, 2025

    Reasons Why a Meditation Retreat in Malaysia Should Be Your Next Getaway

    April 14, 2025

    How a Single Elevated Dog Bowl Improves Your Dog’s Health

    March 20, 2025
    Leave A Reply Cancel Reply

    You must be logged in to post a comment.

    Top Posts

    Why Dialogue Is the Key to Great Storytelling

    July 3, 20252 Views

    Knowing When to Use HCPCS vs CPT Codes: A Guide for Accurate Medical Billing

    June 26, 20255 Views

    Housewarming Gift Ideas

    June 11, 20259 Views

    How to Incorporate Puns in Calls to Action for Better Results

    May 28, 20254 Views

    Edge AI Solution for Traffic Management with NVIDIA Jetson AGX Orin

    May 4, 20259 Views

    Soft Semiconductors: Designing for Flexibility Without Performance Trade-Offs

    April 29, 202521 Views

    The Complete Guide to Buying Central Vacuum Systems Online

    April 24, 202517 Views

    Reasons Why a Meditation Retreat in Malaysia Should Be Your Next Getaway

    April 14, 20258 Views

    The Secret to Scaling: CRM by Rocket and the Future of Smart Business Management

    April 13, 202524 Views

    Maximize Your Hunting Success with the Right Gear and Equipment

    April 3, 202544 Views
    • Home
    • Privacy Policy
    • About Us
    • Disclaimer
    • Contact Us
    © 2025 Pro Magzine. Designed by GP.

    Type above and press Enter to search. Press Esc to cancel.